相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects
Mohammed I. El-Gamal et al.
MOLECULES (2022)
Quantitative and Qualitative Analysis of the Anti-Proliferative Potential of the Pyrazole Scaffold in the Design of Anticancer Agents
George Mihai Nitulescu
MOLECULES (2022)
Targeting CDK4 and CDK6 in cancer
Shom Goel et al.
NATURE REVIEWS CANCER (2022)
A Tale of Two Tails: Efficient Profiling of Protein Degraders by Specific Functional and Target Engagement Readouts
Alexey L. Chernobrovkin et al.
SLAS DISCOVERY (2021)
Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells
Rebeka de Oliveira Pepino et al.
CURRENT MEDICINAL CHEMISTRY (2021)
The evolution of cyclin dependent kinase inhibitors in the treatment of cancer
Komal Jhaveri et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
Trends in kinase drug discovery: targets, indications and inhibitor design
Misty M. Attwood et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK-788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy Volunteers
Steven Zhang et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
AMPK-dependent activation of the Cyclin Y/CDK16 complex controls autophagy
Marc Dohmen et al.
NATURE COMMUNICATIONS (2020)
The kinase polypharmacology landscape of clinical PARP inhibitors
Albert A. Antolin et al.
SCIENTIFIC REPORTS (2020)
Metabolism of JQ1, an inhibitor of bromodomain and extra terminal bromodomain proteins, in human and mouse liver microsomes
Feng Li et al.
BIOLOGY OF REPRODUCTION (2020)
Quantifying CDK inhibitor selectivity in live cells
Carrow I. Wells et al.
NATURE COMMUNICATIONS (2020)
The CCNY (cyclin Y)-CDK16 kinase complex: a new regulator of autophagy downstream of AMPK
Joerg Vervoorts et al.
AUTOPHAGY (2020)
Optimization of pyrazolo[1,5-a]pyrimidines lead to the identification of a highly selective casein kinase 2 inhibitor
Andreas Kraemer et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
CDK16/PCTK1/PCTAIRE1 is highly expressed in melanomas but not in melanocytic nevi or sarcomas
Teruki Yanagi et al.
JOURNAL OF DERMATOLOGY (2019)
CDK16: the pick of the understudied PCTAIRE kinases
Alison Axtman et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity
Fleur M. Ferguson et al.
CELL CHEMICAL BIOLOGY (2019)
CDK16 overexpressed in non-small cell lung cancer and regulates cancer cell growth and apoptosis via a p27-dependent mechanism
Hongtao Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Structural insights into the functional diversity of the CDK-cyclin family
Daniel J. Wood et al.
OPEN BIOLOGY (2018)
Real-Time Determination of the Cell-Cycle Position of Individual Cells within Live Tumors Using FUCCI Cell-Cycle Imaging
Shuya Yano et al.
CELLS (2018)
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement
James D. Vasta et al.
CELL CHEMICAL BIOLOGY (2018)
PCTAIRE1/CDK16/PCTK1 is overexpressed in cutaneous squamous cell carcinoma and regulates p27 stability and cell cycle
Teruki Yanagi et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2017)
Inhibitors of cyclin-dependent kinases as cancer therapeutics
Steven R. Whittaker et al.
PHARMACOLOGY & THERAPEUTICS (2017)
The Identification of Key Genes and Pathways in Glioma by Bioinformatics Analysis
Mingfa Liu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16
Sarah E. Dixon-Clarke et al.
BIOCHEMICAL JOURNAL (2017)
The RNA Polymerase II CTD: The Increasing Complexity of a Low-Complexity Protein Domain
Celia Jeronimo et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
Channing Yu et al.
NATURE BIOTECHNOLOGY (2016)
Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines
Eric Kowarz et al.
BIOTECHNOLOGY JOURNAL (2015)
PCTAIRE1/PCTK1/CDK16: a new oncotarget?
Teruki Yanagi et al.
CELL CYCLE (2015)
Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines
Eric Kowarz et al.
BIOTECHNOLOGY JOURNAL (2015)
FUCCI sensors: powerful new tools for analysis of cell proliferation
N. Zielke et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
Structural characterization of the cyclin-dependent protein kinase family
Jane A. Endicott et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Cdks, cyclins and CKIs: roles beyond cell cycle regulation
Shuhui Lim et al.
DEVELOPMENT (2013)
Aminothiazole-Featured Pirinixic Acid Derivatives As Dual 5-Lipoxygenase and Microsomal Prostaglandin E2 Synthase-1 Inhibitors with Improved Potency and Efficiency in Vivo
Thomas Hanke et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Brain-selective Kinase 2 (BRSK2) Phosphorylation on PCTAIRE1 Negatively Regulates Glucose-stimulated Insulin Secretion in Pancreatic β-Cells
Xin-Ya Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cyclin-Dependent Kinase 16/PCTAIRE Kinase 1 Is Activated by Cyclin Y and Is Essential for Spermatogenesis
Petra Mikolcevic et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates
Randy Suryadinata et al.
BIOSCIENCE REPORTS (2010)
Emerging links between CDK cell cycle regulators and Wnt signaling
Gary Davidson et al.
TRENDS IN CELL BIOLOGY (2010)
Identification of N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor
Maria Gabriella Brasca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Cyclin-dependent kinases: a family portrait
Marcos Malumbres et al.
NATURE CELL BIOLOGY (2009)
Tuning a Three-Component Reaction For Trapping Kinase Substrate Complexes
Alexander V. Statsuk et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Isabel M. Chu et al.
NATURE REVIEWS CANCER (2008)
Selectivity and potency of cyclin-dependent kinase inhibitors
J Sridhar et al.
AAPS JOURNAL (2006)
Exploiting structural principles to design cyclin-dependent kinase inhibitors
M Noble et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases
TA Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
